DUBLIN, Nov. 22, 2022 /PRNewswire/ -- Alkermes plc
(Nasdaq: ALKS) announced today that management will participate in
a fireside chat at the 5th Annual Evercore ISI HealthCONx
Conference on Tuesday, Nov. 29, 2022
at 2:40 p.m. ET (7:40 p.m. GMT). The live webcast may be accessed
under the Investors tab on www.alkermes.com and will be
archived for 14 days.
About Alkermes plc
Alkermes plc is a fully-integrated, global
biopharmaceutical company developing innovative medicines in the
fields of neuroscience and oncology. The company has a portfolio of
proprietary commercial products focused on alcohol dependence,
opioid dependence, schizophrenia and bipolar I disorder, and a
pipeline of product candidates in development for neurological
disorders and cancer. Headquartered in Dublin,
Ireland, Alkermes has a research and development center
in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and a manufacturing facility
in Wilmington, Ohio. For more information, please visit
Alkermes' website at www.alkermes.com.
Contact:
Sandy Coombs
Investor Relations
+1 781 609 6377
Logo -
https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/alkermes-to-participate-in-the-5th-annual-evercore-isi-healthconx-conference-301684242.html